SYF vs VRCA · rev $11.19B vs rev $10.9M
SYF (SYF) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
SYF (SYF) common stock.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
SYF currently screens at market cap $0. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the SYF and VRCA stock pages for the full models.
Not investment advice.